
ADAG
USDAdagene Inc. American Depositary Shares
$1.405-0.185 (-11.635%)
即時價格
Healthcare
生物科技
中國
價格圖表
Loading Chart...
關鍵指標
市場指標
開盤
$1.590
最高
$1.700
最低
$1.300
交易量
0.09M
公司基本面
市值
66.2M
行業
生物科技
國家
China
交易統計
平均交易量
0.09M
交易所
NGM
貨幣
USD
52週範圍
最低 $1.3當前 $1.405最高 $3.16
相關新聞
GlobeNewswire
Adagene Announces First Patient Dosed in Randomized Dose Optimization Cohort of the Phase 2 Study of Muzastotug (ADG126) in Combination with KEYTRUDA® (pembrolizumab) in Microsatellite Stable Colorectal Cancer
Phase 2 clinical trial underway with first patient dosed in October to support a clear path to Phase 3 based on previous alignment with FDA Patients randomized to either 10 or 20 mg/kg of muzastotug, in combination with
查看更多